Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion type Assertion NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_head.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion description "[Taken together, our data demonstrate that downregulation of CXCL16 plays an important role in renal cancer development and progression, and that CXCL16 in RCC is an independent prognostic marker for better patient survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_provenance.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion evidence source_evidence_literature NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_provenance.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion SIO_000772 19070478 NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_provenance.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion wasDerivedFrom befree-2016 NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_provenance.
- NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_assertion wasGeneratedBy ECO_0000203 NP708248.RA-ho_eev3EipFrZc1VKo_E4vH0wDLu7lVsk9HOCXVQao130_provenance.